Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Metabolic syndrome markers and risk of hyperglycemia in pregnancy: a cross-sectional cohort study

Full text
Author(s):
Vernini, Joice M. [1] ; Nicolosi, Bianca F. [1] ; Arantes, Mariana A. [1] ; Costa, Roberto A. [2] ; Magalhaes, Claudia G. [2] ; Corrente, Jose E. [3] ; Lima, Silvana A. M. [4] ; Rudge, Marilza V. [2, 1] ; Calderon, Iracema M. [2, 1]
Total Authors: 9
Affiliation:
[1] Sao Paulo State Univ Unesp, Botucatu Med Sch, Grad Program Obstet Gynecol & Mastol, Sao Paulo - Brazil
[2] Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP - Brazil
[3] Sao Paulo State Univ Unesp, Botucatu Inst Biosci, Dept Biostat, Sao Paulo - Brazil
[4] Sao Paulo State Univ Unesp, Botucatu Med Sch, Dept Nursing, Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: SCIENTIFIC REPORTS; v. 10, n. 1 DEC 3 2020.
Web of Science Citations: 0
Abstract

The aim was to assess the role of Metabolic Syndrome (MetS) diagnostic markers, recommended by three different guidelines, in the prediction of hyperglycemia in pregnancy. This cross-sectional cohort study included 506 non-diabetic women, with a singleton pregnancy, who underwent a diagnostic test for hyperglycemia at 24-28 weeks. Clinical, anthropometric, and laboratory data were obtained. The relationship between MetS markers and the risk of hyperglycemia was evaluated by backward stepwise logistic regression analysis (OR, 95% CI). The limit of statistical significance was 95% (p < 0.05). Triglycerides (TG) >= 150 mg/dL, blood pressure (BP) >= 130/85 mmHg, fasting glucose (FG) >= 100 mg/dL, and waist circumference (WC) > 88 cm were identified as independent risk factors for hyperglycemia in pregnancy. These results might help the selective screening of hyperglycemia in pregnancy. (AU)

FAPESP's process: 12/51257-9 - Investigation on new risk factors and on quality of life related to diabetes or hyperglycemia diagnosis in pregnancy
Grantee:Iracema de Mattos Paranhos Calderon
Support Opportunities: Research Grants - Research in Public Policies for the National Health Care System (PP-SUS)